05/08/2026 20:17
|
Medical, Health & Aged Care
* Total global revenues of $1.7 billion for the second quarter, an increase of 30% from the prior year
* BRUKINSA (zanubrutinib) global revenues of $1.2 billion for the second quarter, an...